DBP B — Double Bond Pharmaceutical International AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK30.92m
- SEK26.93m
- SEK1.09m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 28.39 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -820.98% | ||
| Operating Margin | -712.02% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 1.16 | 0.96 | 1.24 | 1.37 | 1.09 | n/a | n/a | 35.18% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Double Bond Pharmaceutical International AB (publ) is a Sweden- based pharmaceutical company primarily engaged in manufacturing of pharmaceuticals, operations in medical technology and other related activities. The Company scope of activity revolves around developing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma as well as diabetes. The Company main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on company's technology. Double Bond Pharmaceutical International AB products are sold under separate trademarks and collaboration on product development is done together with other companies in the field.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 21st, 2014
- Public Since
- July 10th, 2015
- No. of Employees
- 10
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 108,120,108
- Address
- Virdings Alle 32 B, UPPSALA, 754 50
- Web
- Phone
- Auditors
- Grant Thornton Sweden AB
Upcoming Events for DBP B
Similar to DBP B
Cessatech A/S
AktieTorget Stock Exchange
Odi Pharma AB (publ)
AktieTorget Stock Exchange
FAQ
What is the Double Bond Pharmaceutical International AB (publ) share price?
As of Today at 20:18 UTC, shares in Double Bond Pharmaceutical International AB (publ) are trading at SEK0.29. This share price information is delayed by 15 minutes.
How has the Double Bond Pharmaceutical International AB (publ) share price performed this year?
Shares in Double Bond Pharmaceutical International AB (publ) last closed at SEK0.29 and the price had moved by -53.72% over the past 365 days. In terms of relative price strength the Double Bond Pharmaceutical International AB (publ) share price has underperformed the FTSE Global All Cap Index by -54.88% over the past year.
What are the analyst and broker recommendations for Double Bond Pharmaceutical International AB (publ)?
There is no consensus recommendation for this security.
Find out moreWhat is the Double Bond Pharmaceutical International AB (publ) dividend yield?
Double Bond Pharmaceutical International AB (publ) does not currently pay a dividend.
Does Double Bond Pharmaceutical International AB (publ) pay a dividend?
Double Bond Pharmaceutical International AB (publ) does not currently pay a dividend.
When does Double Bond Pharmaceutical International AB (publ) next pay dividends?
Double Bond Pharmaceutical International AB (publ) does not currently pay a dividend.
How do I buy Double Bond Pharmaceutical International AB (publ) shares?
To buy shares in Double Bond Pharmaceutical International AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Double Bond Pharmaceutical International AB (publ)?
As of the previous close price of SEK0.29, shares in Double Bond Pharmaceutical International AB (publ) had a market capitalisation of SEK30.92m.
Where are Double Bond Pharmaceutical International AB (publ) shares listed?
Here are the trading details for Double Bond Pharmaceutical International AB (publ):
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: DBP B
What kind of share is Double Bond Pharmaceutical International AB (publ)?
Based on an overall assessment of its quality, value and momentum Double Bond Pharmaceutical International AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Double Bond Pharmaceutical International AB (publ) share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Double Bond Pharmaceutical International AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Double Bond Pharmaceutical International AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -9.9%.
As of the last closing price of SEK0.29, shares in Double Bond Pharmaceutical International AB (publ) were trading -23.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Double Bond Pharmaceutical International AB (publ) PE Ratio?
The Double Bond Pharmaceutical International AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.29.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Double Bond Pharmaceutical International AB (publ)?
We do not have data on Double Bond Pharmaceutical International AB (publ)'s directors